Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements

No new government funds committed to no-deal medicines plans

- PMLiVE

$450m diagnostics sale will fuel more Syncona biotech funding

Radiopharmaceuticals firm sold to Braco Imaging

- PMLiVE

FDA clears Dupixent as first-ever drug for chronic rhinosinusitis with nasal polyps

Could add $1bn to revenues, say analysts

- PMLiVE

AZ’s Imfinzi joins immunotherapy drive in small cell lung cancer

Tecentriq the leader in setting

A new EU in the making, what lies ahead for pharma?

Big decisions on Europe's leaders and strategy await

Empowering the MS patient through shared decision making

Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered

Blue Latitude Health

- PMLiVE

What pharma marketers can learn from Disney

Why we need to continue to innovate, and surprise our audience

- PMLiVE

Virgo Health expands senior team with new hires

Agency strengthens senior team

- PMLiVE

FDA fast-tracks Jardiance for heart failure review

Would challenge Novartis' Entresto

- PMLiVE

Good data is nothing without advocacy

In a world focused on improving outcomes, the days when drugs sold themselves on data alone have long gone. While the need for good data is indisputable, it is now...

Porterhouse Medical Group

- PMLiVE

Charity launches real-world medical cannabis study

Ex-government advisor David Nutt involved

- PMLiVE

AbbVie CEO Gonzalez defends Allergan takeover

Group's revenues will replace Humira loss

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links